Market revenue in 2022 | USD 5,292.7 million |
Market revenue in 2030 | USD 13,131.9 million |
Growth rate | 12% (CAGR from 2022 to 2030) |
Largest segment | Consumables |
Fastest growing segment | Consumables |
Historical data covered | 2018 - 2021 |
Base year for estimation | 2022 |
Forecast period covered | 2023 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Software, Instruments, Consumables |
Key market players worldwide | Illumina Inc, Thermo Fisher Scientific Inc, Pacific Biosciences of California Inc, Birks Group Inc Class A, Qiagen NV, Agilent Technologies Inc, PerkinElmer, ProPhase Labs Inc, Azenta Inc, Macrogenics Inc |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to antibody production market will help companies and investors design strategic landscapes.
Consumables was the largest segment with a revenue share of 55.94% in 2022. Horizon Databook has segmented the Europe antibody production market based on software, instruments, consumables covering the revenue growth of each sub-segment from 2018 to 2030.
Horizon Databook provides a detailed overview of continent-level data and insights on the Europe antibody production market, including forecasts for subscribers. This continent databook contains high-level insights into Europe antibody production market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account